Literature DB >> 30607007

CKD autophagy activation and skeletal muscle atrophy-a preliminary study of mitophagy and inflammation.

Yue Yue Zhang1, Li Jie Gu1, Jin Fang Bao2, Wei Jie Yuan3, Juan Huang1, Min Chao Cai1, Hong Lei Yu1, Wei Zhang1.   

Abstract

BACKGROUND/
OBJECTIVES: Long-lived proteins and organelles, such as mitochondria and the sarcoplasmic reticulum, are degraded by autophagy. However, the specific role of autophagy in chronic kidney disease (CKD) muscle atrophy is still undefined. SUBJECTS/
METHODS: This was a cross-sectional study with 20 subjects and 11 controls. Autophagy induction was studied in human skeletal muscle biopsies from CKD patients and controls by comparing the cross-sectional areas of muscle fibers, protein, and mRNA expression of autophagy-related genes and the appearance of autophagosomes.
RESULTS: The cross-sectional area of muscle fibers was decreased in CKD patients as compared with the control group. CKD was associated with activated autophagy and mitophagy, as measured by the elevated mRNA and protein expression of BNIP3, (microtubule-associated proteins 1 A/1B light chain 3, also MAP1LC3) LC3, p62, PINK1, and PARKIN in the skeletal muscle and isolated mitochondria of the CKD group. Electron microscopy and immunohistofluorescence analysis showed mitochondrial engulfment by autophagosomes. Mitophagy was further demonstrated by the colocalization of LC3 and p62 puncta with the mitochondrial outer membrane protein TOM20. In addition, degradative FOXO3 (Forkhead box O3) was activated and synthetic mTOR (mammalian target of rapamycin) was inhibited, whereas the upstream mediators VPS34 (class III PI3-kinase) and AKT (protein kinase B, PKB) were activated in CKD patients.
CONCLUSIONS: Hyperactive autophagy and mitophagy may play important roles in CKD muscle atrophy. Autophagy was activated by FOXO3 translational factors in the skeletal muscle tissues of CKD patients, which maybe a new way of intervention for CKD muscle atrophy.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30607007     DOI: 10.1038/s41430-018-0381-x

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  58 in total

1.  Malnutrition: a frequent misdiagnosis for hemodialysis patients.

Authors:  William E Mitch
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

2.  Wasting, but not malnutrition, predicts cardiovascular mortality in end-stage renal disease.

Authors:  Peter Stenvinkel; Olof Heimbürger; Bengt Lindholm
Journal:  Nephrol Dial Transplant       Date:  2004-07-06       Impact factor: 5.992

Review 3.  Autophagy: renovation of cells and tissues.

Authors:  Noboru Mizushima; Masaaki Komatsu
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

4.  Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases.

Authors:  Jennifer M Sacheck; Jon-Philippe K Hyatt; Anna Raffaello; R Thomas Jagoe; Roland R Roy; V Reggie Edgerton; Stewart H Lecker; Alfred L Goldberg
Journal:  FASEB J       Date:  2006-11-20       Impact factor: 5.191

5.  Metabolic and morphometric profile of muscle fibers in chronic hemodialysis patients.

Authors:  Michael I Lewis; Mario Fournier; Huiyuan Wang; Thomas W Storer; Richard Casaburi; Arthur H Cohen; Joel D Kopple
Journal:  J Appl Physiol (1985)       Date:  2011-10-20

6.  Impaired muscle oxygen metabolism in uremic children: improved after renal transplantation.

Authors:  Naoko Matsumoto; Shiro Ichimura; Takafumi Hamaoka; Takuya Osada; Motoshi Hattori; Sanpei Miyakawa
Journal:  Am J Kidney Dis       Date:  2006-09       Impact factor: 8.860

Review 7.  Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM).

Authors:  Juan Jesús Carrero; Peter Stenvinkel; Lilian Cuppari; T Alp Ikizler; Kamyar Kalantar-Zadeh; George Kaysen; William E Mitch; S Russ Price; Christoph Wanner; Angela Y M Wang; Pieter ter Wee; Harold A Franch
Journal:  J Ren Nutr       Date:  2013-03       Impact factor: 3.655

8.  Autophagy is required to maintain muscle mass.

Authors:  Eva Masiero; Lisa Agatea; Cristina Mammucari; Bert Blaauw; Emanuele Loro; Masaaki Komatsu; Daniel Metzger; Carlo Reggiani; Stefano Schiaffino; Marco Sandri
Journal:  Cell Metab       Date:  2009-12       Impact factor: 27.287

9.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression.

Authors:  Stewart H Lecker; R Thomas Jagoe; Alexander Gilbert; Marcelo Gomes; Vickie Baracos; James Bailey; S Russ Price; William E Mitch; Alfred L Goldberg
Journal:  FASEB J       Date:  2004-01       Impact factor: 5.191

Review 10.  Mitochondrial Quality Control and Muscle Mass Maintenance.

Authors:  Vanina Romanello; Marco Sandri
Journal:  Front Physiol       Date:  2016-01-12       Impact factor: 4.566

View more
  13 in total

1.  Uremic metabolites impair skeletal muscle mitochondrial energetics through disruption of the electron transport system and matrix dehydrogenase activity.

Authors:  Trace Thome; Zachary R Salyers; Ravi A Kumar; Dongwoo Hahn; Fabian N Berru; Leonardo F Ferreira; Salvatore T Scali; Terence E Ryan
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-10       Impact factor: 4.249

2.  Skeletal Muscle Phenotype in Patients Undergoing Long-Term Hemodialysis Awaiting Kidney Transplantation.

Authors:  Jean-Sébastien Souweine; Fares Gouzi; Éric Badia; Pascal Pomies; Valérie Garrigue; Marion Morena; Maurice Hayot; Jacques Mercier; Bronia Ayoub; Moglie Le Quintrec; Fabrice Raynaud; Jean-Paul Cristol
Journal:  Clin J Am Soc Nephrol       Date:  2021-11       Impact factor: 8.237

3.  Mitochondria in neurodegeneration.

Authors:  Charleen T Chu
Journal:  Curr Opin Physiol       Date:  2022-04-01

Review 4.  Skeletal Muscle Complications in Chronic Kidney Disease.

Authors:  Ashley D Troutman; Eliott Arroyo; Kenneth Lim; Ranjani N Moorthi; Keith G Avin
Journal:  Curr Osteoporos Rep       Date:  2022-09-23       Impact factor: 5.163

Review 5.  Pathophysiological mechanisms leading to muscle loss in chronic kidney disease.

Authors:  Xiaonan H Wang; William E Mitch; S Russ Price
Journal:  Nat Rev Nephrol       Date:  2021-11-08       Impact factor: 42.439

6.  Inhibition of IL-6/JAK/STAT3 pathway rescues denervation-induced skeletal muscle atrophy.

Authors:  Ziwei Huang; Lou Zhong; Jianwei Zhu; Hua Xu; Wenjing Ma; Lilei Zhang; Yuntian Shen; Betty Yuen-Kwan Law; Fei Ding; Xiaosong Gu; Hualin Sun
Journal:  Ann Transl Med       Date:  2020-12

7.  Chronic kidney disease exacerbates ischemic limb myopathy in mice via altered mitochondrial energetics.

Authors:  Fabian N Berru; Sarah E Gray; Trace Thome; Ravi A Kumar; Zachary R Salyers; Madeline Coleman; Kerri O'Malley; Leonardo F Ferreira; Scott A Berceli; Salvatore T Scali; Terence E Ryan
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

8.  Antioxidant Apigenin Relieves Age-Related Muscle Atrophy by Inhibiting Oxidative Stress and Hyperactive Mitophagy and Apoptosis in Skeletal Muscle of Mice.

Authors:  Dongtao Wang; Yajun Yang; Xiaohu Zou; Jing Zhang; Zena Zheng; Ziwei Wang
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-10-15       Impact factor: 6.053

9.  Calycosin inhibited autophagy and oxidative stress in chronic kidney disease skeletal muscle atrophy by regulating AMPK/SKP2/CARM1 signalling pathway.

Authors:  Rong Hu; Ming-Qing Wang; Ling-Yu Liu; Hai-Yan You; Xiao-Hui Wu; Yang-Yang Liu; Yan-Jing Wang; Lu Lu; Wei Xiao; Lian-Bo Wei
Journal:  J Cell Mol Med       Date:  2020-09-10       Impact factor: 5.310

Review 10.  Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy.

Authors:  Tadashi Yoshida; Patrice Delafontaine
Journal:  Cells       Date:  2020-08-26       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.